Emerging Symptomatic Treatment of Chronic Traumatic Encephalopathy (CTE): a narrative review

IntroductionChronic traumatic encephalopathy (CTE) is an emergent neurodegenerative tauopathy well characterized pathologically but with limited consensus about clinical criteria. The clinical features include cognitive, behavioral, and motor symptoms such as parkinsonism, gait, balance disorder, and bulbar impairment. Their recognition derives from retrospective studies in pathologically confirmed CTE patients. This is one of the main reasons for the lack of specific pharmacological studies targeting symptoms or pathologic pathways of this disease.Areas coveredIn this narrative review, we overview the possible symptomatic treatment options for CTE, based on pathological similarities with other neurodegenerative diseases that may share common pathological pathways with CTE. The PubMed database was screened for articles addressing the symptomatic treatment of CTE and Traumatic Encephalopathy Syndrome (TES). Additional references were retrieved by reference cross-check and retained if pertinent to the subject. The clinicaltrials.gov database was screened for ongoing trials on the treatment of CTE.Expert opinionThe similarities with the other tauopathies allow us, in the absence of disease-specific evidence, to translate some knowledge from these neurodegenerative disorders to CTE's symptomatic treatment, but any conclusion should be drawn cautiously and a patient-tailored strategy should be always preferred balancing the risks and benefits of each treatment.

Automated summary

Chronic traumatic encephalopathy (CTE) is a neurodegenerative disease characterized by pathological tau protein build-up, but there is limited consensus on clinical criteria. The clinical features include cognitive, behavioral, and motor symptoms, with similarities to other tauopathies. This narrative review examines possible treatment options for CTE based on similarities with other neurodegenerative disorders.